|
Volumn 102, Issue 4, 2005, Pages 757-758
|
Aprotinin and hemostasis [1]
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
APROTININ;
PLACEBO;
SODIUM CHLORIDE;
ANTIFIBRINOLYTIC AGENT;
HEMOSTATIC AGENT;
TRANEXAMIC ACID;
ADULT;
ANESTHESIA INDUCTION;
BLEEDING;
BLEEDING TENDENCY;
BLOOD TRANSFUSION;
BODY WEIGHT;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CRANIOFACIAL SURGERY;
DEEP VEIN THROMBOSIS;
DEMOGRAPHY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG SAFETY;
GLASGOW OUTCOME SCALE;
HEMATOCRIT;
HEMOSTASIS;
HISTOPATHOLOGY;
HUMAN;
INFANT;
LETTER;
MAJOR CLINICAL STUDY;
MENINGIOMA;
MINI MENTAL STATE EXAMINATION;
NEURILEMOMA;
NEUROSURGERY;
PATIENT SELECTION;
PLASTIC SURGERY;
POSTOPERATIVE PERIOD;
PREOPERATIVE EVALUATION;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
VESTIBULAR SYSTEM;
DRUG COMBINATION;
INTRAVENOUS DRUG ADMINISTRATION;
METHODOLOGY;
NOTE;
ANTIFIBRINOLYTIC AGENTS;
APROTININ;
DRUG THERAPY, COMBINATION;
HEMOSTASIS, SURGICAL;
HEMOSTATICS;
HUMANS;
INFUSIONS, INTRAVENOUS;
NEUROSURGICAL PROCEDURES;
TRANEXAMIC ACID;
|
EID: 18744380687
PISSN: 00223085
EISSN: 00223085
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (2)
|
References (8)
|